Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients

<div>Schematic representation of the trial design. The timing of panobinostat dosing and the collection of samples utilized in these analyses are illustrated.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients 